Premium
The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis
Author(s) -
Rossier P.,
van Erven S.,
Wade D. T.
Publication year - 2000
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1046/j.1468-1331.2000.00142.x
Subject(s) - spasticity , medicine , multiple sclerosis , modified ashworth scale , spastic , paraplegia , weakness , physical medicine and rehabilitation , physical therapy , range of motion , spinal cord , surgery , cerebral palsy , psychiatry
The effects of magnesium glycerophosphate oral therapy on spasticity was studied in a 35‐year‐old woman with severe spastic paraplegia resulting from multiple sclerosis (MS). We found a significant improvement in the spasticity after only 1 week from the onset of the treatment on the modified Ashworth scale, an improvement in the range of motion and in the measures of angles at resting position in lower limbs. No side‐effects were reported and there was no weakness in the arms during the treatment.